gastroenterology
Research

Diclofenac caution over higher GI bleed risk

The NSAID diclofenac should not be used first line because it has “considerably higher” GI bleeding risks and cardiovascular risk than some other NSAIDs, a Danish study has concluded. With few prospective head to head trials of NSAID risks, researchers examined the cardiovascular risks of diclofenac initiation compared with initiation of other NSAIDs and paracetamol ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic